Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 274

1.

Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial.

Kowey PR, Dorian P, Mitchell LB, Pratt CM, Roy D, Schwartz PJ, Sadowski J, Sobczyk D, Bochenek A, Toft E; Atrial Arrhythmia Conversion Trial Investigators.

Circ Arrhythm Electrophysiol. 2009 Dec;2(6):652-9. doi: 10.1161/CIRCEP.109.870204. Epub .

PMID:
19948506
[PubMed - indexed for MEDLINE]
Free Article
2.

Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation.

Pratt CM, Roy D, Torp-Pedersen C, Wyse DG, Toft E, Juul-Moller S, Retyk E, Drenning DH; Atrial Arrhythmia Conversion Trial (ACT-III) Investigators.

Am J Cardiol. 2010 Nov 1;106(9):1277-83. doi: 10.1016/j.amjcard.2010.06.054.

PMID:
21029824
[PubMed - indexed for MEDLINE]
3.

Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial.

Roy D, Pratt CM, Torp-Pedersen C, Wyse DG, Toft E, Juul-Moller S, Nielsen T, Rasmussen SL, Stiell IG, Coutu B, Ip JH, Pritchett EL, Camm AJ; Atrial Arrhythmia Conversion Trial Investigators.

Circulation. 2008 Mar 25;117(12):1518-25. doi: 10.1161/CIRCULATIONAHA.107.723866. Epub 2008 Mar 10.

PMID:
18332267
[PubMed - indexed for MEDLINE]
Free Article
4.

Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial.

Camm AJ, Toft E, Torp-Pedersen C, Vijayaraman P, Juul-Moller S, Ip J, Beatch GN, Dickinson G, Wyse DG; Scene 2 Investigators.

Europace. 2012 Jun;14(6):804-9. doi: 10.1093/europace/eur416. Epub 2012 Jan 29.

PMID:
22291438
[PubMed - indexed for MEDLINE]
Free Article
5.

Population pharmacokinetic-pharmacodynamic analysis of vernakalant hydrochloride injection (RSD1235) in atrial fibrillation or atrial flutter.

Mao Z, Wheeler JJ, Townsend R, Gao Y, Kshirsagar S, Keirns JJ.

J Pharmacokinet Pharmacodyn. 2011 Oct;38(5):541-62. doi: 10.1007/s10928-011-9207-3. Epub 2011 Jul 24.

PMID:
21786177
[PubMed - indexed for MEDLINE]
6.

A multicenter, open-label study of vernakalant for the conversion of atrial fibrillation to sinus rhythm.

Stiell IG, Roos JS, Kavanagh KM, Dickinson G.

Am Heart J. 2010 Jun;159(6):1095-101. doi: 10.1016/j.ahj.2010.02.035.

PMID:
20569725
[PubMed - indexed for MEDLINE]
7.

Vernakalant: RSD 1235, RSD-1235, RSD1235.

[No authors listed]

Drugs R D. 2007;8(4):259-65. Review.

PMID:
17596113
[PubMed - indexed for MEDLINE]
8.

Vernakalant hydrochloride: A novel atrial-selective agent for the cardioversion of recent-onset atrial fibrillation in the emergency department.

Stiell IG, Dickinson G, Butterfield NN, Clement CM, Perry JJ, Vaillancourt C, Calder LA.

Acad Emerg Med. 2010 Nov;17(11):1175-82. doi: 10.1111/j.1553-2712.2010.00915.x. Erratum in: Acad Emerg Med. 2011 Feb;18(2):224.

PMID:
21175515
[PubMed - indexed for MEDLINE]
9.

Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group.

Nørgaard BL, Wachtell K, Christensen PD, Madsen B, Johansen JB, Christiansen EH, Graff O, Simonsen EH.

Am Heart J. 1999 Jun;137(6):1062-9.

PMID:
10347332
[PubMed - indexed for MEDLINE]
10.

A randomized, placebo-controlled study of vernakalant (oral) for the prevention of atrial fibrillation recurrence after cardioversion.

Torp-Pedersen C, Raev DH, Dickinson G, Butterfield NN, Mangal B, Beatch GN.

Circ Arrhythm Electrophysiol. 2011 Oct;4(5):637-43. doi: 10.1161/CIRCEP.111.962340. Epub 2011 Aug 14.

PMID:
21841207
[PubMed - indexed for MEDLINE]
Free Article
11.

Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutter.

Hohnloser SH, Dorian P, Straub M, Beckmann K, Kowey P.

J Am Coll Cardiol. 2004 Jul 7;44(1):99-104.

PMID:
15234416
[PubMed - indexed for MEDLINE]
Free Article
12.

A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery.

Tisdale JE, Padhi ID, Goldberg AD, Silverman NA, Webb CR, Higgins RS, Paone G, Frank DM, Borzak S.

Am Heart J. 1998 May;135(5 Pt 1):739-47.

PMID:
9588402
[PubMed - indexed for MEDLINE]
13.

Vernakalant: conversion of atrial fibrillation in patients with ischemic heart disease.

Torp-Pedersen C, Camm AJ, Butterfield NN, Dickinson G, Beatch GN.

Int J Cardiol. 2013 Jun 5;166(1):147-51. doi: 10.1016/j.ijcard.2011.10.108. Epub 2011 Nov 21.

PMID:
22108512
[PubMed - indexed for MEDLINE]
14.

Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group.

Sung RJ, Tan HL, Karagounis L, Hanyok JJ, Falk R, Platia E, Das G, Hardy SA.

Am Heart J. 1995 Apr;129(4):739-48.

PMID:
7900626
[PubMed - indexed for MEDLINE]
15.

Intravenous vernakalant: a review of its use in the management of recent-onset atrial fibrillation.

Duggan ST, Scott LJ.

Drugs. 2011 Jan 22;71(2):237-52. doi: 10.2165/10489050-000000000-00000. Review. Erratum in: Drugs. 2011 Feb 12;71(3):381.

PMID:
21275448
[PubMed - indexed for MEDLINE]
16.

Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery.

Mooss AN, Wurdeman RL, Mohiuddin SM, Reyes AP, Sugimoto JT, Scott W, Hilleman DE, Seyedroudbari A.

Am Heart J. 2000 Jul;140(1):176-80.

PMID:
10874282
[PubMed - indexed for MEDLINE]
17.

Pharmacokinetics of novel atrial-selective antiarrhythmic agent vernakalant hydrochloride injection (RSD1235): influence of CYP2D6 expression and other factors.

Mao ZL, Wheeler JJ, Clohs L, Beatch GN, Keirns J.

J Clin Pharmacol. 2009 Jan;49(1):17-29. doi: 10.1177/0091270008325148. Epub 2008 Oct 16.

PMID:
18927241
[PubMed - indexed for MEDLINE]
18.

Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery.

VanderLugt JT, Mattioni T, Denker S, Torchiana D, Ahern T, Wakefield LK, Perry KT, Kowey PR.

Circulation. 1999 Jul 27;100(4):369-75.

PMID:
10421596
[PubMed - indexed for MEDLINE]
Free Article
19.

Safe and effective conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009.

Crijns HJ, Van Gelder IC, Walfridsson H, Kulakowski P, Rónaszéki A, Dedek V, Malm A, Almgren O.

Heart Rhythm. 2006 Nov;3(11):1321-31. Epub 2006 Jul 8.

PMID:
17074639
[PubMed - indexed for MEDLINE]
20.

[Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].

Zhang HC, Guo JH, Fang Q, Zheng YA, Sun YM, Zhu WQ, Wan Z, Guo JX, Ge JB, Han SM.

Zhonghua Yi Xue Za Zhi. 2005 Mar 30;85(12):798-801. Chinese.

PMID:
15949393
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk